Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Hitachi Chemical Company, Ltd.
  6. News
  7. Summary
    4217   JP3785000005

HITACHI CHEMICAL COMPANY, LTD.

(4217)
SummaryChartsNewsRatingsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Exopharm Limited Reaches Agreement to Conduct A Research Collaboration with Showa Denko Materials Co., Ltd

09/08/2021 | 01:14am EST

Exopharm Limited has reached an agreement to conduct a research collaboration with Showa Denko Materials Co., Ltd. (SDMC). Under the Feasibility Study Agreement, SDMC will evaluate the LEAPTM technology platform within its regenerative medicine business unit at its Yokohama facility. This evaluation will allow Exopharm's patent-protected LEAP technology and know-how to be studied within SDMC's Yokohama facility and by its experts ­ assisted by Exopharm. If the research project is successful there is potential for a further future commercial agreement. Showa Denko is an established international supplier of drug and other chemical substances. If this feasibility study is successful, exosomes purified using LEAP could be yet another valuable product in their portfolio," said Dr Chris Baldwin, Chief Commercial Officer of Exopharm. "This collaboration follows the work are doing with the Finnish Red Cross Blood Service. As the number of collaborations build, their confidence that LEAP could become the global standard for purifying exosome medicines continues to grow.


ę S&P Capital IQ 2021
All news about HITACHI CHEMICAL COMPANY, LTD.
09/22Showa Denko Materials Co., Ltd. Announces Executive Changes, Effective January 4, 2022
CI
09/08Exopharm Limited Reaches Agreement to Conduct A Research Collaboration with Showa Denko..
CI
07/08Sustainable Battery Solutions, Inc entered into a definitive agreement to acquire major..
CI
07/07Japan Fine Ceramics Co. Ltd. signed a basic agreement to acquire SDMC's Ceramics Busine..
CI
06/07Polaris Private Equity Fund V, L.P. managed by Polaris Capital Group Co., Ltd. signed a..
CI
01/28Nantong Jianghai Capacitor Co. Ltd. cancelled the acquisition of Capacitor Business And..
CI
2020Hitachi's 1st-half operating profit sags 39%, raises outlook on China
AQ
2020Hitachi mulls selling half of its stake in machinery subsidiary
AQ
2020Showa Denko Materials Co., Ltd. Announces the Adoption of MCL-LW-900G/910G for the Prin..
CI
2020Hitachi Chemical Company, Ltd. will Change its Name to Showa Denko Materials Co., Ltd
CI
More news
Chart HITACHI CHEMICAL COMPANY, LTD.
Duration : Period :
Hitachi Chemical Company, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Hisashi Maruyama President, Chief Executive Officer & Director
Mitsuyoshi Toyoshima Chief Financial Officer
Kazuyuki Tanaka Chairman
Mitsuo katayose Director, CTO & Managing Executive Officer
Richard E. Dyck Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
HITACHI CHEMICAL COMPANY, LTD.1.09%8 983
ECOLAB INC.4.56%64 830
SIKA AG47.81%54 933
GIVAUDAN SA21.26%45 220
YUNNAN ENERGY NEW MATERIAL CO., LTD.87.33%37 016
HOSHINE SILICON INDUSTRY CO., LTD.357.54%25 712